DMRA (DMRA) Stock Price & Analysis
DMRA (DMRA) fell 1.33% to USD 29.66 as of September 8, 2026 at 14:09 UTC, according to Nexqual real-time market data.
DMRA last closed at USD 29.66; the session ranged USD 29.6–30.74 on volume of 76,564 shares. Market capitalization is —, with a 52-week range of USD 2.45–38.33 (NCM). Source: Nexqual, September 8, 2026 at 14:09 UTC.
Key Statistics (as of September 8, 2026 at 14:09 UTC)
| Price | USD 29.66 |
|---|---|
| Change | ▼ 1.33% (down) |
| Previous Close | USD 29.66 |
| Open | USD 29.66 |
| Day Range | USD 29.6 – 30.74 |
| 52-Week Range | USD 2.45 – 38.33 |
| Volume | 76,564 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (DMRA)
Nexqual's technical model rates DMRA "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of September 8, 2026 at 14:09 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49 (neutral) |
| vs SMA50 | Below (USD 29.73) |
| MACD | -0.16 (negative) |
From DMRA's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRAX | Praxis Precision Medicines, Inc | USD 352.24 | ▼ 0.82% |
| CYCN | Cyclerion Therapeutics, Inc. | USD 2.96 | ▼ 30.47% |
| OLMA | Olema Pharmaceuticals, Inc. | USD 10.79 | ▲ 0.56% |
| EVAX | Evaxion A/S | USD 3.3 | ▲ 7.14% |
| PRFX | PRF Technologies Ltd. | USD 0.97 | ▼ 1.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:09 UTC. This page is informational and not investment advice.